Research & Development to Escalate the Growth of Sterility Testing Market

Fri, 03 May 2019 2:12

Market Scenario

Sterility testing is done in the scientific laboratories, research & development facilities for making sure the absence of microbes while performing tests in the sterile vessels and instruments. Contamination due to bacteria and viruses may affect the tests results and medical diagnosis as well. Sterility testing is of vital importance while performing tests for precise results.

Rise in prevalence of chronic and severe diseases and increasing R&D investments are the key factors driving the sterility testing market. Some of the other factors supporting the market growth are ongoing technological advancements in quick resulting sterility tests and rise in the healthcare expenditure. According to the American Association of Diabetes Educators, in 2017, there were more than 30.3 million people suffering from diabetes in the U.S. Moreover, 84.1 million adults in the U.S. suffered from prediabetes in 2017.

However, poor healthcare infrastructure in the developing regions including Latin America and the Middle East & Africa, stringent regulatory guidelines, and time consuming approval processes are some the factors which are likely to hamper the market growth during the forecast period 2019–2026.

Segmental Analysis

The global sterility testing market is segmented on the basis of test type, product type, application, and region.

Based on test type, the sterility testing market is segmented into rapid sterility tests and conventional sterility tests. Rapid sterility tests segment is expected to grow rapidly owing to the ongoing research & development regarding the diagnostic testing of sterility.

Based on product type, the market is segregated into instruments, kits & reagents, and others. Instruments segment is expected to grow at higher pace amongst product type during the forecast period 2019–2026.

Based on application, the market is divided into medical devices manufacturing, biopharmaceutical manufacturing, and others. Medical devices manufacturing segment is the most lucrative segment owing to ongoing research & development regarding the sterility testing medical devices.

Regional Analysis

In terms of region, the sterility testing market is segregated into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

North America dominates the sterility testing market owing to the constantly growing population and increasing severity of the diseased conditions. According to the United States Census Bureau, population of the U.S. in 2018 was over 327,167,434. Other factor supporting the market growth is rise in prevalence of diseases harming sterility of the products.

Europe is expected to experience the significant growth during the forecast period 2019–2026. Growth of Europe sterility testing market is attributed to the ongoing research & development in the sterility testing field.

Asia Pacific is the fastest growing market for sterility testing owing to the huge population base and increasing demand for sterility testing products in the region. Developing healthcare infrastructure in the region is also the key factor supporting the market growth.

Key Players

Some of the key players in the global sterility testing market are Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc., bioMerieux SA, Sartorius AG, Becton, Dickinson and Company and Rapid Micro Biosystems, Inc.

Segmentation

By Test Type

  • Rapid Sterility Tests
    • Solid phase Cytometry
    • Bioluminescence
    • Flow Cytometry
    • Immunological methods
    • Nucleic acid amplification
    • Others
  • Conventional Sterility Tests
    • Membrane Filtration
    • Immersion Test

By Product Type

  • Instruments
  • Kits & Reagents
  • Others

By Application

  • Medical Devices Manufacturing
  • Biopharmaceutical Manufacturing
  • Others

By Region

  • North America (U.S and Canada)
  • Europe (Germany, France, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
  • MEA (Saudi Arabia, UAE, South Africa, and Rest of MEA)
  • Latin America (Brazil, Argentina, and Rest of Latin America)